GPRC6A as a novel kokumi receptor responsible for enhanced taste preferences by ornithine

  1. Faculty of Health Sciences, Kio University, Nara, Japan
  2. Osaka University Graduate School of Dentistry, Osaka, Japan
  3. Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

Peer review process

Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the editors and peer reviewers.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Richard Palmiter
    Howard Hughes Medical Institute, University of Washington, Seattle, United States of America
  • Senior Editor
    Michael Taffe
    University of California, San Diego, San Diego, United States of America

Reviewer #1 (Public review):

Summary:

This paper contains what could be described as a "classic" approach towards evaluating a novel taste stimuli in an animal model, including standard behavioral tests (some with nerve transections), taste nerve physiology, and immunocytochemistry of taste cells of the tongue. The stimulus being tested is ornithine, from a class of stimuli called "kokumi" (in terms of human taste); these kokumi stimuli appear to enhance other canonical tastes, increasing what are essentially hedonic attributes of other stimuli. The mechanism for ornithine detection is thought to be GPRC6A receptors expressed in taste cells. The authors showed evidence for this in an earlier paper with mice; this paper evaluates ornithine taste in a rat model, and comes to a similar conclusion, albeit with some small differences between the two rodent species.

Strengths:

The data show effects of ornithine on taste/intake in laboratory rats: In two-bottle and briefer intake tests, adding ornithine results in higher intake of most, but all not all stimuli tested. Bilateral chorda tympani (CT) nerve cuts or the addition of GPRC6A antagonists decreased or eliminated these effects. Ornithine also evoked responses by itself in the CT nerve, but mainly at higher concentrations; at lower concentrations it potentiated the response to monosodium glutamate. Finally, immunocytochemistry of taste cell expression indicated that GPRC6A was expressed predominantly in the anterior tongue, and co-localized (to a small extent) with only IP3R3, indicative of expression in a subset of type II taste receptor cells.

Weaknesses:

As the authors are aware, it is difficult to assess a complex human taste with complex attributes, such as kokumi, in an animal model. In these experiments they attempt to uncover mechanistic insights about how ornithine potentiates other stimuli by using a variety of established experimental approaches in rats. They partially succeed by finding evidence that GPRC6A may mediate effects of ornithine when it is used at lower concentrations. In the revision they have scaled back their interpretations accordingly. A supplementary experiment measuring certain aspects of the effects of ornithine added to Miso soup in human subjects is included for the express purpose of establishing that the kokumi sensation of a complex solution is enhanced by ornithine; however, they do not use any such complex solutions in the rat studies. Moreover, the sample size of the human experiment is (still) small - it really doesn't belong in the same manuscript with the rat studies.

Reviewer #2 (Public review):

Summary:

The authors used rats to determine the receptor for a food-related perception (kokumi) that has been characterized in humans. They employ a combination of behavioral, electrophysiological, and immunohistochemical results to support their conclusion that ornithine-mediated kokumi effects are mediated by the GPRC6A receptor. They complemented the rat data with some human psychophysical data. I find the results intriguing, but believe that the authors overinterpret their data.

Strengths:

The authors provide compelling evidence that ornithine enhances the palatability of several chemical stimuli (i.e., IMP, MSG, MPG, Intralipos, sucrose, NaCl, quinine). Ornithine also increases CT nerve responses to MSG. Additionally, the authors provide evidence that the effects of ornithine are mediated by GPRC6A, a G-protein-coupled receptor family C group 6 subtype A, and that this receptor is expressed primarily in fungiform taste buds. Taken together, these results indicate that ornithine enhances the palatability of multiple taste stimuli in rats and that the enhancement is mediated, at least in part, within fungiform taste buds. This is an important finding that could stand on its own. The question of whether ornithine produces these effects by eliciting kokumi-like perceptions (see below) should be presented as speculation in the Discussion section.

Weaknesses:

I am still unconvinced that the measurements in rats reflect the "kokumi" taste percept described in humans. The authors conducted long-term preference tests, 10-min avidity tests and whole chorda tympani (CT) nerve recordings. None of these procedures specifically model features of "kokumi" perception in humans, which (according to the authors) include increasing "intensity of whole complex tastes (rich flavor with complex tastes), mouthfulness (spread of taste and flavor throughout the oral cavity), and persistence of taste (lingering flavor)." While it may be possible to develop behavioral assays in rats (or mice) that effectively model kokumi taste perception in humans, the authors have not made any effort to do so. As a result, I do not think that the rat data provide support for the main conclusion of the study--that "ornithine is a kokumi substance and GPRC6A is a novel kokumi receptor."

Why are the authors hypothesizing that the primary impacts of ornithine are on the peripheral taste system? While the CT recordings provide support for peripheral taste enhancement, they do not rule out the possibility of additional central enhancement. Indeed, based on the definition of human kokumi described above, it is likely that the effects of kokumi stimuli in humans are mediated at least in part by the central flavor system.

The authors include (in the supplemental data section) a pilot study that examined the impact of ornithine on variety of subjective measures of flavor perception in humans. The presence of this pilot study within the larger rat study does not really mice sense. While I agree with the authors that there is value in conducting parallel tests in both humans and rodents, I think that this can only be done effectively when the measurements in both species are the same. For this reason, I recommend that the human data be published in a separate article.

The authors indicated on several occasions (e.g., see Abstract) that ornithine produced "synergistic" effects on the CT nerve response to chemical stimuli. "Synergy" is used to describe a situation where two stimuli produce an effect that is greater than the sum of the response to each stimulus alone (i.e., 2 + 2 = 5). As far as I can tell, the CT recordings in Fig. 3 do not reflect a synergism.

Reviewer #3 (Public review):

Summary:

In this study the authors set out to investigate whether GPRC6A mediates kokumi taste initiated by the amino acid L-ornithine. They used Wistar rats, a standard laboratory strain, as the primary model and also performed an informative taste test in humans, in which miso soup was supplemented with various concentrations of L-ornithine. The findings are valuable and overall the evidence is solid. L-Ornithine should be considered to be a useful test substance in future studies of kokumi taste and the class C G protein coupled receptor known as GPRC6A (C6A) along with its homolog, the calcium-sensing receptor (CaSR) should be considered candidate mediators of kokumi taste. The researchers confirmed in rats their previous work on Ornithine and C6A in mice (Mizuta et al Nutrients 2021).

Strengths:

The overall experimental design is solid based on two bottle preference tests in rats. After determining the optimal concentration for L-Ornithine (1 mM) in the presence of MSG, it was added to various tastants including: inosine 5'-monophosphate; monosodium glutamate (MSG); mono-potassium glutamate (MPG); intralipos (a soybean oil emulsion); sucrose; sodium chloride (NaCl; salt); citric acid (sour) and quinine hydrochloride (bitter). Robust effects of ornithine were observed in the cases of IMP, MSG, MPG and sucrose; and little or no effects were observed in the cases of sodium chloride, citric acid; quinine HCl. The researchers then focused on the preference for Ornithine-containing MSG solutions. Inclusion of the C6A inhibitors Calindol (0.3 mM but not 0.06 mM) or the gallate derivative EGCG (0.1 mM but not 0.03 mM) eliminated the preference for solutions that contained Ornithine in addition to MSG. The researchers next performed transections of the chord tympani nerves (with sham operation controls) in anesthetized rats to identify a role of the chorda tympani branches of the facial nerves (cranial nerve VII) in the preference for Ornithine-containing MSG solutions. This finding implicates the anterior half-two thirds of the tongue in ornithine-induced kokumi taste. They then used electrical recordings from intact chorda tympani nerves in anesthetized rats to demonstrate that ornithine enhanced MSG-induced responses following the application of tastants to the anterior surface of the tongue. They went on to show that this enhanced response was insensitive to amiloride, selected to inhibit 'salt tastant' responses mediated by the epithelial Na+ channel, but eliminated by Calindol. Finally they performed immunohistochemistry on sections of rat tongue demonstrating C6A positive spindle-shaped cells in fungiform papillae that partially overlapped in its distribution with the IP3 type-3 receptor, used as a marker of Type-II cells, but not with (i) gustducin, the G protein partner of Tas1 receptors (T1Rs), used as a marker of a subset of type-II cells; or (ii) 5-HT (serotonin) and Synaptosome-associated protein 25 kDa (SNAP-25) used as markers of Type-III cells.

At least two other receptors in addition to C6A might mediate taste responses to ornithine: (i) the CaSR, which binds and responds to multiple L-amino acids (Conigrave et al, PNAS 2000), and which has been previously reported to mediate kokumi taste (Ohsu et al., JBC 2010) as well as responses to Ornithine (Shin et al., Cell Signaling 2020); and (ii) T1R1/T1R3 heterodimers which also respond to L-amino acids and exhibit enhanced responses to IMP (Nelson et al., Nature 2001). These alternatives are appropriately discussed and, taken together, the experimental results favor the authors' interpretation that C6A mediates the Ornithine responses. The authors provide preliminary data in Suppl. 3 for the possibility of co-expression of C6A with the CaSR.

Weaknesses:

The authors point out that animal models pose some difficulties of interpretation in studies of taste and raise the possibility in the Discussion that umami substances may enhance the taste response to ornithine (Line 271, Page 9).

One issue that is not addressed, and could be usefully addressed in the Discussion, relates to the potential effects of kokumi substances on the threshold concentrations of key tastants such as glutamate. Thus, an extension of taste distribution to additional areas of the mouth (previously referred to as 'mouthfulness') and persistence of taste/flavor responses (previously referred to as 'continuity') could arise from a reduction in the threshold concentrations of umami and other substances that evoke taste responses.

The status of one of the compounds used as an inhibitor of C6A, the gallate derivative EGCG, as a potential inhibitor of the CaSR or T1R1/T1R3 is unknown. It would have been helpful to show that a specific inhibitor of the CaSR failed to block the ornithine response.

It would have been helpful to include a positive control kokumi substance in the two bottle preference experiment (e.g., one of the known gamma glutamyl peptides such as gamma-glu-Val-Gly or glutathione), to compare the relative potencies of the control kokumi compound and Ornithine, and to compare the sensitivities of the two responses to C6A and CaSR inhibitors.

Author response:

The following is the authors’ response to the original reviews.

Reviewer #1 (Public review):

Summary:

This paper contains what could be described as a "classic" approach towards evaluating a novel taste stimuli in an animal model, including standard behavioral tests (some with nerve transections), taste nerve physiology, and immunocytochemistry of the tongue. The stimulus being tested is ornithine, from a class of stimuli called "kokumi", which are stimuli that enhance other canonical tastes, increasing essentially the hedonic attributes of these other stimuli; the mechanism for ornithine detection is thought to be GPRC6A receptors expressed in taste cells. The authors showed evidence for this in an earlier paper with mice; this paper evaluates ornithine taste in a rat model.

Strengths:

The data show the effects of ornithine on taste: in two-bottle and briefer intake tests, adding ornithine results in a higher intake of most, but not all, stimuli tests. Bilateral nerve cuts or the addition of GPRC6A antagonists decrease this effect. Small effects of ornithine are shown in whole-nerve recordings.

Weaknesses:

The conclusion seems to be that the authors have found evidence for ornithine acting as a taste modifier through the GPRC6A receptor expressed on the anterior tongue. It is hard to separate their conclusions from the possibility that any effects are additive rather than modulatory. Animals did prefer ornithine to water when presented by itself. Additionally, the authors refer to evidence that ornithine is activating the T1R1-T1R3 amino acid taste receptor, possibly at higher concentrations than they use for most of the study, although this seems speculative. It is striking that the largest effects on taste are found with the other amino acid (umami) stimuli, leading to the possibility that these are largely synergistic effects taking place at the tas1r receptor heterodimer.

We would like to thank Reviewer #1 for the valuable comments. Our basis for considering ornithine as a taste modifier stems from our observation that a low concentration of ornithine (1 mM), which does not elicit a preference on its own, enhances the preference for umami substances, sucrose, and soybean oil through the activation of the GPRC6A receptor. Notably, this receptor is not typically considered a taste receptor. The reviewer suggested that the enhancement of umami taste might be due to potentiation occurring at the TAS1R receptor heterodimer. However, we propose that a different mechanism may be at play, as an antagonist of GPRC6A almost completely abolished this enhancement. In the revised manuscript, we will endeavor to provide additional information on the role of ornithine as a taste modifier acting through the GPRC6A receptor.

Reviewer #2 (Public review):

Summary:

The authors used rats to determine the receptor for a food-related perception (kokumi) that has been characterized in humans. They employ a combination of behavioral, electrophysiological, and immunohistochemical results to support their conclusion that ornithine-mediated kokumi effects are mediated by the GPRC6A receptor. They complemented the rat data with some human psychophysical data. I find the results intriguing, but believe that the authors overinterpret their data.

Strengths:

The authors examined a new and exciting taste enhancer (ornithine). They used a variety of experimental approaches in rats to document the impact of ornithine on taste preference and peripheral taste nerve recordings. Further, they provided evidence pointing to a potential receptor for ornithine.

Weaknesses:

The authors have not established that the rat is an appropriate model system for studying kokumi. Their measurements do not provide insight into any of the established effects of kokumi on human flavor perception. The small study on humans is difficult to compare to the rat study because the authors made completely different types of measurements. Thus, I think that the authors need to substantially scale back the scope of their interpretations. These weaknesses diminish the likely impact of the work on the field of flavor perception.

We would like to thank Reviewer #2 for the valuable comments and suggestions. Regarding the question of whether the rat is an appropriate model system for studying kokumi, we have chosen this species for several reasons: it is readily available as a conventional experimental model for gustatory research; the calcium-sensing receptor (CaSR), known as the kokumi receptor, is expressed in taste bud cells; and prior research has demonstrated the use of rats in kokumi studies involving gamma Glu-Val-Gly (Yamamoto and Mizuta, Chem. Senses, 2022).

We acknowledge that fundamentally different types of measurements were conducted in the human psychophysical study and the rat study. Kokumi can indeed be assessed and expressed in humans; however, we do not currently have the means to confirm that animals experience kokumi in the same way that humans do. Therefore, human studies are necessary to evaluate kokumi, a conceptual term denoting enhanced flavor, while animal studies are needed to explore the potential underlying mechanisms of kokumi. We believe that a combination of both human and animal studies is essential, as is the case with research on sugars. While sugars are known to elicit sweetness, it is unclear whether animals perceive sweetness identically to humans, even though they exhibit a strong preference for sugars. In the revised manuscript, we will incorporate additional information to address the comments raised by the reviewer. We will also carefully review and revise our previous statements to ensure accuracy and clarity.

Reviewer #3 (Public review):

Summary:

In this study, the authors set out to investigate whether GPRC6A mediates kokumi taste initiated by the amino acid L-ornithine. They used Wistar rats, a standard laboratory strain, as the primary model and also performed an informative taste test in humans, in which miso soup was supplemented with various concentrations of L-ornithine. The findings are valuable and overall the evidence is solid. L-Ornithine should be considered to be a useful test substance in future studies of kokumi taste and the class C G protein-coupled receptor known as GPRC6A (C6A) along with its homolog, the calcium-sensing receptor (CaSR) should be considered candidate mediators of kokumi taste.

Strengths:

The overall experimental design is solid based on two bottle preference tests in rats. After determining the optimal concentration for L-Ornithine (1 mM) in the presence of MSG, it was added to various tastants, including inosine 5'-monophosphate; monosodium glutamate (MSG); mono-potassium glutamate (MPG); intralipos (a soybean oil emulsion); sucrose; sodium chloride (NaCl); citric acid and quinine hydrochloride. Robust effects of ornithine were observed in the cases of IMP, MSG, MPG, and sucrose, and little or no effects were observed in the cases of sodium chloride, citric acid, and quinine HCl. The researchers then focused on the preference for Ornithine-containing MSG solutions. The inclusion of the C6A inhibitors Calindol (0.3 mM but not 0.06 mM) or the gallate derivative EGCG (0.1 mM but not 0.03 mM) eliminated the preference for solutions that contained Ornithine in addition to MSG. The researchers next performed transections of the chord tympani nerves (with sham operation controls) in anesthetized rats to identify the role of the chorda tympani branches of the facial nerves (cranial nerve VII) in the preference for Ornithine-containing MSG solutions. This finding implicates the anterior half-two thirds of the tongue in ornithine-induced kokumi taste. They then used electrical recordings from intact chorda tympani nerves in anesthetized rats to demonstrate that ornithine enhanced MSG-induced responses following the application of tastants to the anterior surface of the tongue. They went on to show that this enhanced response was insensitive to amiloride, selected to inhibit 'salt tastant' responses mediated by the epithelial Na+ channel, but eliminated by Calindol. Finally, they performed immunohistochemistry on sections of rat tongue demonstrating C6A positive spindle-shaped cells in fungiform papillae that partially overlapped in its distribution with the IP3 type-3 receptor, used as a marker of Type-II cells, but not with (i) gustducin, the G protein partner of Tas1 receptors (T1Rs), used as a marker of a subset of type-II cells; or (ii) 5-HT (serotonin) and Synaptosome-associated protein 25 kDa (SNAP-25) used as markers of Type-III cells.

Weaknesses:

The researchers undertook what turned out to be largely confirmatory studies in rats with respect to their previously published work on Ornithine and C6A in mice (Mizuta et al Nutrients 2021).

The authors point out that animal models pose some difficulties of interpretation in studies of taste and raise the possibility in the Discussion that umami substances may enhance the taste response to ornithine (Line 271, Page 9). They miss an opportunity to outline the experimental results from the study that favor their preferred interpretation that ornithine is a taste enhancer rather than a tastant.

At least two other receptors in addition to C6A might mediate taste responses to ornithine: (i) the CaSR, which binds and responds to multiple L-amino acids (Conigrave et al, PNAS 2000), and which has been previously reported to mediate kokumi taste (Ohsu et al., JBC 2010) as well as responses to Ornithine (Shin et al., Cell Signaling 2020); and (ii) T1R1/T1R3 heterodimers which also respond to L-amino acids and exhibit enhanced responses to IMP (Nelson et al., Nature 2001). While the experimental results as a whole favor the authors' interpretation that C6A mediates the Ornithine responses, they do not make clear either the nature of the 'receptor identification problem' in the Introduction or the way in which they approached that problem in the Results and Discussion sections. It would be helpful to show that a specific inhibitor of the CaSR failed to block the ornithine response. In addition, while they showed that C6A-positive cells were clearly distinct from gustducin-positive, and thus T1R-positive cells, they missed an opportunity to clearly differentiate C6A-expressing taste cells and CaSR-expressing taste cells in the rat tongue sections.

It would have been helpful to include a positive control kokumi substance in the two-bottle preference experiment (e.g., one of the known gamma-glutamyl peptides such as gamma-glu-Val-Gly or glutathione), to compare the relative potencies of the control kokumi compound and Ornithine, and to compare the sensitivities of the two responses to C6A and CaSR inhibitors.

The results demonstrate that enhancement of the chorda tympani nerve response to MSG occurs at substantially greater Ornithine concentrations (10 and 30 mM) than were required to observe differences in the two bottle preference experiments (1.0 mM; Figure 2). The discrepancy requires careful discussion and if necessary further experiments using the two-bottle preference format.

We would like to thank Reviewer #3 for the valuable comments and helpful suggestions. We propose that ornithine has two stimulatory actions: one acting on GPRC6A, particularly at lower concentrations, and another on amino acid receptors such as T1R1/T1R3 at higher concentrations. Consequently, ornithine is not preferable at lower concentrations but becomes preferable at higher concentrations. For our study on kokumi, we used a low concentration (1 mM) of ornithine. The possibility mentioned in the Discussion that 'the umami substances may enhance the taste response to ornithine' is entirely speculative. We will reconsider including this description in the revised version. As the reviewer suggested, in addition to GPRC6A, ornithine may bind to CaSR and/or T1R1/T1R3 heterodimers. However, we believe that ornithine mainly binds to GPRC6A, as a specific inhibitor of this receptor almost completely abolished the enhanced response to umami substances, and our immunohistochemical study indicated that GPRC6A-expressing taste cells are distinct from CaSR-expressing taste cells (see Supplemental Fig. 3). We conducted essentially the same experiments using gamma-Glu-Val-Gly in Wistar rats (Yamamoto and Mizuta, Chem. Senses, 2022) and compared the results in the Discussion. The reviewer may have misunderstood the chorda tympani results: we added the same concentration (1 mM) used in the two-bottle preference test to MSG (Fig. 5-B). Fig. 5-A shows nerve responses to five concentrations of plain ornithine. In the revised manuscript, we will strive to provide more precise information reflecting the reviewer’s comments.

Recommendations for the authors:

Reviewer #1 (Recommendations for the authors):

(1) The behavioral effects found with the CPRC6A antagonists are not entirely convincing, as the antagonist is seemingly just mixed up in the solution with the stimuli. There are no control experiments demonstrating that the antagonists do not have a taste themselves.

We mixed the antagonists into both liquids used in the two-bottle preference test to eliminate any potential taste effects of the antagonists themselves. In the electrophysiological experiments, the antagonist was incorporated into the solution after confirming that it did not elicit any appreciable response in the taste nerve.

(2) The effects of ornithine found with quinine did not have a satisfying explanation - if there is some taste cell-taste cell modulation that accounts for the taste enhancement, why is the quinine less aversive? Why is it not enhanced like the other compounds?

The effects of ornithine on quinine responses remain difficult to explain. A previous study (Tokuyama et al., Chem Pharm Bull, 2006) proposed that ornithine prevents bitter substances from binding to bitter receptors, although this hypothesis lacks definitive evidence. In the present study, our findings suggest that the binding of quinine to bitter receptors is essential, as another agonist, gallate, also enhanced the preference for quinine, but this effect was abolished by EGCG, a GPRC6A antagonist (see Supplemental Fig. 2).

(3) Unless I am missing something, there appears to be no quantitative analysis of the immunocytochemical data, just assertions.

We have made quantitative analyses in the revised text, and the following sentences have been added: “Approximately 11% of GPRC6A-positive cells overlapped with IP3R3 (9 double-positive cells/80 GPRC6A-positive cells), while approximately 8.3% of IP3R3-positive cells expressed GPRC6A (9 double-positive /109 IP3R3-positive cells). In addition, GPRC6A-positive cells were unlikely to colocalize with a-gustducin, another marker for a subset of type II cells, in single taste cells (0 double-positive cell/93 GPRC6A-positive cells). Regarding type III cell markers, GPRC6A-positive cells were unlikely to colocalize with 5-HT in single taste cells (0 double-positive cell/75 GPRC6A-positive cells).”

(4) The hallmarks of Kokumi taste include descriptors such as "thickness", and "mouthfeel", which sound like potential somatosensory attributes. Perhaps the authors should consider this possibility for at least some of the effects found.

The term kokumi, a Japanese word, refers to a phenomenon in which the flavor of complexly composed food is enhanced through certain processes, making them more delicious. To date, kokumi has been described using the representative terms thickness, mouthfulness, and continuity, originally introduced in the first paper on kokumi by Ueda et al. (1990). However, these terms are derived from Japanese and may not fully convey the nuances of the original language when translated into these simple English words. In particular, thickness is often interpreted as referring to physical properties such as viscosity or somatosensory sensations. Since kokumi inherently lacks somatosensory elements, this revised paper adopts alternative terms and explanations for the three components of kokumi to prevent misunderstanding and confusion.

Therefore, to clarify that kokumi attributes are inherently gustatory, thickness is replaced with intensity of whole complex tastes (rich flavor with complex tastes), emphasizing the synergistic effects of a variety of tastes rather than the mere enhancement of a single flavor. Mouthfulness is clarified as not referring to mouthfeel (the tactile sensation a food gives in the mouth) but rather as spread of taste and flavor throughout the oral cavity, describing how the flavor fills the mouth. Continuity is replaced with persistence of taste (lingering flavor).

(5) I don't think the human experiment (S1) belongs to the paper, even as a supplementary bit of data. It's only 17 subjects, they are all female, and we don't know anything about how they were selected, even though it states they are all students/staff at Kio. Were any of them lab members? Were they aware of the goals of the experiment? Could simply increasing the amount of solute in the soup make it seem thicker? This (sparse) data seems to have been shoehorned into the paper without enough detail/justification.

Despite the reviewer’s suggestion, we would like to include the human experiment because the rationale of the present study is to confirm, through a human sensory test, that the kokumi of a complex solution (in this case, miso soup) is enhanced by the addition of ornithine. This is followed by basic animal experiments to investigate the underlying mechanisms. Therefore, this human study serves an important role.

The total number of participants increased to 22 (19 women and three men) following an additional experiment with 5 new participants. New results have been shown in Supplemental Figure 1 with statistical analyses. The rewritten parts are as follows:

We recruited 22 participants (19 women and three men, aged 21-28 years) from Kio University who were not affiliated with our laboratory, including students and staff members. All participants passed a screening test based on taste sensitivity. According to the responses obtained from a pre-experimental questionnaire, we confirmed that none of the participants had any sensory abnormalities, eating disorders, or mental disorders, or were taking any medications that may potentially affect their sense of taste. All participants were instructed not to eat or drink anything for 1 hour prior to the start of the experiment. We provided them with a detailed explanation of the experimental procedures, including safety measures and personal data protection, without revealing the specific goals of the study.

(6) The introduction could be more concise - for example, when describing Kokumi stimuli such as ornithine and its possible receptors, the authors do not need to add the detail about how this stimulus was deduced from adding clams to the soup. Details like this can be reserved for the discussion.

Thank you for this comment. We have tried to shorten the Introduction.

(7) Line 86: awkward phrasing - this doesn't need to be a rhetorical question.

We have deleted the sentence.

(8) Supplementary Figure 1: The labels on the figure say "Miso soup in 1 mM Orn" when the Orn is dissolved into the soup.

Thank you for pointing out our mistake. We have changed the description, such as “1 mM Orn in miso soup”.

Reviewer #2 (Recommendations for the authors):

Major concerns

(1) The impact of "kokumi" taste ligands on food perception appears to be profound in humans. This observation is fascinating because it implies that molecules like ornithine impact a variety of flavor perceptions, some of which are non-gustatory in nature (e.g., spread, mouthfulness and harmony). What remains unclear is whether "kokumi" ligands produce analogous sensations in rodents. If they don't, then rodents are an inappropriate model system for studying the impact of kokumi on flavor perceptions. The authors fail to address this key issue, and uncritically assume that kokumi ligands produce sensations like thickness, mouthfulness, and continuity in rodents. For this reason, the authors' reference to GPRC6A as a kokumi receptor is inappropriate.

Thank you very much for the valuable comments. The term kokumi refers to a phenomenon in which the flavor of complexly composed foods is enhanced through certain processes, making them more delicious. It is an important concept in the field of food science, which studies how to make prepared dishes more enjoyable. Kokumi is also considered a higher-order, profound cognitive function evaluated by humans who experience a wide variety of foods. However, it is unclear whether animals, particularly experimental animals, can perceive kokumi in the same way humans do.

To date, kokumi has been described using the representative terms thickness, mouthfulness, and continuity, originally introduced in the first paper on kokumi by Ueda et al. (1990). However, these terms are derived from Japanese and may not fully convey the nuances of the original language when translated into these simple English words. In particular, thickness is often interpreted as referring to physical properties such as viscosity or somatosensory sensations. Since kokumi inherently lacks somatosensory elements, this revised paper adopts alternative terms and explanations for the three components of kokumi to prevent misunderstanding and confusion.

Therefore, to clarify that kokumi attributes are inherently gustatory, thickness is replaced with intensity of whole complex tastes (rich flavor with complex tastes), emphasizing the synergistic effects of a variety of tastes rather than the mere enhancement of a single flavor. Mouthfulness is clarified as not referring to mouthfeel (the tactile sensation a food gives in the mouth) but rather as spread of taste and flavor throughout the oral cavity, describing how the flavor fills the mouth. Continuity is replaced with persistence of taste (lingering flavor).

Rodents are thought to possess basic taste functions similar to humans, such as the expression of taste receptors, including kokumi receptors, in taste cells. Regardless of whether rodents can perceive kokumi, findings from studies on rodents may provide insights into aspects of the kokumi concept as experienced by humans.

Indeed, the results of this study indicate that ornithine enhances umami, sweetness, fat taste, and saltiness, leading to the enhancement of complex flavors—referred to as intensity of whole taste. The activation of various taste cells, resulting in the enhancement of multiple tastes, may contribute to the sensation of flavors spreading throughout the oral cavity. Furthermore, the strong enhancement of MSG and MPG suggests that glutamate contributes to the mouthfulness and persistence of taste characteristic of kokumi.

(2) A related concern is that the authors did not make any measurements that model kokumi sensations documented in the literature. For example, they would need to develop behavioral/electrophysiological measurements that reflect the known effects of kokumi ligands on flavor perception (i.e., increases in intensity, spread, continuity, richness, harmony, and punch). For example, ornithine is thought to produce more "punch" (i.e., a more rapid rise in intensity). This could be manifested as a more rapid rise in peripheral taste response or a more rapid fMRI response in the taste cortex. Alternatively, ornithine is thought to increase "continuity" (i.e., make the taste response more persistent). This response would presumably be manifested as a peripheral taste response that adapts more slowly or a more persistent fMRI response. As it stands, the authors have documented that ornithine increases (i) the preference of rats for some chemical stimuli, but not others; and (ii) the response of the CT nerve to some but not all taste stimuli.

In animal experiments, it is challenging to examine each attribute of kokumi. The increase of complex tastes can be investigated through behavioral experiments and neural activity recordings. However, phenomena such as spread or harmony, which arise from profound human judgments, are difficult to validate in animal studies.

While it was possible to examine persistence through neural responses to tastants, all stimuli were rinsed at 30 seconds after onset of stimulation, so the exact duration of persistence was not investigated. However, since the MSG response was enhanced approximately 1.5 times with the addition of ornithine, it is strongly suggested that the duration might also have been prolonged.

Regarding punch, no differences were observed in the neural responses when ornithine was added, likely because the phasic response already had a rapid onset.

In the context of fMRI studies, there has been a report that adding glutathione to mixtures of umami and salt solutions increases responses (Goto et al. Chem Senses, 2016). However, research specifically examining the attributes of kokumi has not yet been reported.

(3) The quality of the SNAP-25 immunohistochemistry is poor (see Figure 7D), with lots of seemingly nonspecific staining in and outside the taste bud.

The quality of the SNAP-25 is not poor. It is known that SNAP-25 labels not only type III cells but also the dense network of intragemmal nerve fibers (Tizzano et al., Immunohistochemical Analysis of Human Vallate Taste Buds. Chem Senses.40:655-60, 2015). Therefore, lots of seemingly nonspecific staining is due to intense SNAP-25-immunoreactivity of the nerve fibers.

(4) The authors need to drastically scale back the scope of their conclusions. What they can say is that ornithine appears to enhance the taste responses of rats to a variety of taste stimuli and that this effect appears to be mediated by the GPRC6A receptor. They cannot use their data to address kokumi effects in humans, as they have not attempted to model any of these effects. Given the known problems with pharmacological blocking agents (e.g., nonspecificity), the authors would significantly strengthen their case if they could generate similar results in a GPRC6A knockout mouse.

Our research approach begins with confirming in humans that the addition of ornithine to complex foods (such as miso soup) induces kokumi. Based on this confirmation, we conduct fundamental studies using animal models to investigate the peripheral taste mechanisms underlying the expression of kokumi.

It is possible that the key to kokumi expression lies in the enhancement of desirable tastes (particularly umami) and the suppression of unpleasant tastes. Moving forward, we will deepen our fundamental research on the action of ornithine mediated through GPRC6A, including studies using knockout mice.

(5) The introduction is too long. Much of the discussion of kokumi perception in humans should either be removed or shortened considerably.

Following the reviewer’s suggestion, the introduction has been shortened.

(6) I recommend that the authors break up the Methods and Results sections into different experiments. This would enable the authors to provide separate rationales for each procedure. For instance, the authors conducted a variety of different behavioral procedures (e.g., long- and short-term preference tests, and preference tests with and without GPRC6A receptor antagonists).

Rather than following the reviewer’s suggestion, we have added subheadings to describe the purpose of each experiment. This approach would help readers better understand the experimental flow, as each experiment is relatively straightforward.

(7) The inclusion of the human data is odd for two reasons. First, the measurements used to assess the impact of ornithine on flavor perception in humans were totally different than those used in rats. This makes it impossible to compare the human and rat datasets. Second, the human study was rather limited in scope, had small effect sizes, and had a lot of individual variation. For these reasons, the human data are not terribly helpful. I recommend that the authors remove the human data from this paper, and publish them as part of a more extensive study on humans.

Despite the reviewer’s suggestion, we would like to include the human experiment because the rationale of the present study is to confirm, through a human sensory test, that the kokumi of a complex solution (in this case, miso soup) is enhanced by the addition of ornithine. This is followed by basic animal experiments to investigate the underlying mechanisms. Therefore, this human study serves an important role. The considerable variation in the scores suggests that evaluating the three kokumi attributes is challenging and likely influenced by differences in judgment criteria among participants.

The total number of participants increased to 22 (19 women and three men) following an additional experiment with 5 new participants. New results have been shown in Supplemental Figure 1 with statistical analyses. The rewritten parts are as follows:

We recruited 22 participants (19 women and three men, aged 21-28 years) from Kio University who were not affiliated with our laboratory, including students and staff members. All participants passed a screening test based on taste sensitivity. According to the responses obtained from a pre-experimental questionnaire, we confirmed that none of the participants had any sensory abnormalities, eating disorders, or mental disorders, or were taking any medications that may potentially affect their sense of taste. All participants were instructed not to eat or drink anything for 1 hour prior to the start of the experiment. We provided them with a detailed explanation of the experimental procedures, including safety measures and personal data protection, without revealing the specific goals of the study.

(8) While the use of English is generally good, there are many instances where the English is a bit awkward. I recommend that the authors ask a native English speaker to edit the text.

Thank you for this comment. The text has been edited by a native English speaker.

Minor concerns

(1) Lines 13-14: The authors state that "the concept of 'kokumi' has garnered significant attention in gustatory physiology and food science." This is an exaggeration. Kokumi has generated considerable interest in food science but has yet to generate much interest in gustatory physiology.

We have rewritten this part: “The concept of “kokumi” has generated considerable interest in food science but kokumi has not been well studied in gustatory physiology.”

(2) Line 20: The use of "specific taste" is unclear in this context. The authors indicate (in Figure 5A) that 1 mM ornithine generates a CT nerve response. They also reveal (in Figure 1A) that rats do not prefer 1 mM ornithine over water. The results from a preference test do not provide insight into whether a solution can be tasted; they merely demonstrate a lack of preference for that solution. Based on these data, the authors cannot infer that 1 mM ornithine cannot be tasted.

We agree with the reviewer’s comment. Ornithine at 1 mM concentration may have a weak taste because this solution elicited a small neural response (Fig. 5-A). We have rewritten the text: “… at a concentration without preference for this solution.”

(3) Line 44: Sensory information from foods enters the oral and the nasal cavity.

The nasal cavity has been added.

(5) Lines 59: The terms "thickness", "mouthfulness" and "continuity" are not intuitive in English, and may reflect, at least in part, a failure in translation. The word thickness implies a tactile sensation (e.g., owing to high viscosity), but the authors use it to indicate a flavor that is more intense and onsets more quickly. The word mouthfulness is supposed to indicate that a flavor is experienced throughout the oral cavity. The problem here is that this happens with all tastants, independent of the presence of substances like ornithine. Indeed, taste buds occur in a limited portion of the oral epithelium, but we nevertheless experience tastes throughout the oral cavity, owing to a phenomenon called tactile referral (see the following reference: Todrank and Bartoshuk, 1991, A taste illusion: taste sensation localized by touch" Physiology & Behavior 50:1027-1031). The word continuity does not imply that the taste is long-lasting or persistent.

These three attributes were originally introduced by Ueda et al. (1990), who translated Japanese terms describing the profound characteristics of kokumi, which are deeply rooted in Japanese culinary culture. However, these simply translated terms have caused global misunderstanding and confusion, because they sound like somatosensory rather than gustatory descriptions. Therefore, to clarify that kokumi attributes are inherently gustatory, in the revised version we use the terms “intensity of whole complex tastes (rich flavor with complex tastes)” instead of thickness, “mouthfulness (spread of taste and flavor throughout the oral cavity),” and “persistence of taste (lingering flavor)” instead of continuity.

The results of this study indicate that ornithine enhances umami, sweetness, fat taste, and saltiness, leading to the enhancement of complex flavors—referred to as intensity of whole taste. The activation of various taste cells, resulting in the enhancement of multiple tastes, may contribute to the sensation of flavors spreading throughout the oral cavity. Furthermore, the strong enhancement of MSG and MPG suggests that glutamate contributes to the mouthfulness and persistence of taste characteristic of kokumi.

(6) Figure legends: The authors provide results of statistical comparisons in several of the figures. They need to explain what statistical procedures were performed. As it stands, it is impossible to interpret the asterisks provided.

We have explained statistical procedures in each Figure legend.

(7) I did not see any reference to the sources of funding or any mention of potential conflicts of interest.

We have added the following information:

Funding: JSPS KAKENHI Grant Numbers JP17K00935 (to TY) and JP22K11803(to KU).

Declaration of interests: The authors declare that they have no competing interests.

Reviewer #3 (Recommendations for the authors):

(1) I suggest that the authors increase their level of interest in glutathione and gamma-glutamyl peptides. This might include an appropriate gamma-glutamyl control substance in the two-bottle preference study (see Public Review). It might also include more careful attention to the work that identified glutathione as an activator of the CaSR (Wang et al., JBC 2006) and the nature of its binding site on the CaSR which overlaps with its site for L-amino acids (Broadhead et al., JBC 2011). This latter article also identified S-methyl glutathione, in which the free-SH group is blocked, as a high-potency activator of the CaSR. It would be expected to show comparable potency to gamma-glu-Val-Gly in assays of kokumi taste.

We have appropriately referenced glutathione and gamma-Glu-Val-Gly, potent agonists of CaSR, where necessary. In our previous study (Yamamoto and Mizuta, Chem Senses, 2022), we examined the additive effects of these substances on basic taste stimuli in rodents, and the results were compared in greater detail with those obtained from the addition of ornithine in the present study. We have also discussed the potential binding of ornithine to other receptors, including CaSR and T1R1/T1R3 heterodimers.

(2) Figures:

-None of the figures were labelled with their Figure numbers. I have inferred the Figure numbers from the legends and their positions in the pdf.

We are sorry for this inconvenience.

- The labelling of Figure 1 and Figure 2 are problematic. In Figure 1 it should be made clear that the horizontal axes refer to the Ornithine concentration. In Figure 2 it should be made clear that the horizontal axes refer to the tastant concentrations (MSG, IMP, etc) and that the Ornithine concentrations were fixed at either zero or 1.0 mM.

We are sorry for the lack of information about the horizontal axes. We have explained the horizontal axes in figure legends in Figs. 1 and 2. The labelling of both figures has also been modified to make this clear.

- Figure 3B: 'Control' should appear at the top of this panel since the panels that follow all refer to it.

Following the reviewer’s suggestion, we have added ‘Control’ at the top of Figure 3B.

- Figure 5A. Provide a label for the test substance, presumably Ornithine.

Yes, we have added ‘Ornithine’.

- Figure 7 would be strengthened by the inclusion of immunohistochemistry analyses of the CaSR.

We are sorry that we did not analyze immunohistochemistry for the CaSR because a previous study precisely had analyzed the CaSR expression on taste cells in rats. We have analyzed co-expression of GPRC6A and CaSR (see Supplemental Figure 3).

(3) Other Matters:

- Line 38: list the five basic taste modalities here.

Yes, we have included the five basic taste modalities here.

- Line 107: 'even if ... kokumi ... is less developed in rodents' - if there is evidence that kokumi is less developed in rodents it should be cited here.

We cannot cite any references here because no studies have compared the perception of kokumi between humans and rodents.

- Line 308: 'recently we conducted experiments in rats using gallate ...' - the authors appear to imply that they performed the research in Reference 43, however, I was unable to find an overlap between the two lists of authors.

We are not doing a similar study as the research in Reference 43 (40 in the revised paper). Following the result that gallate is an agonist of GPRC6A as shown by Reference 43, we were interested in doing similar behavioral experiments using gallate instead of ornithine.

The sentences have been rewritten to avoid misunderstanding.

- Line 506: the sections are said to be 20 mm thick - should this read 20 micrometers?

Thank you. We have changed to 20 micrometers.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation